Retroviral Vector WPRE Replacement for Safe Transgene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Retroviral vector systems, particularly those containing the Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (WPRE), pose a tumorigenic risk due to the expression of the X-protein, which can promote oncogenesis, and existing solutions either compromise transgene expression or do not adequately address the tumorigenic potential.
Innovation Solution
Replacing the WPRE with a short, unrelated spacer or stuffer nucleotide sequence (SNS) in retroviral and lentiviral vectors to enhance transgene expression while eliminating the X-protein's tumorigenic potential, thereby increasing the safety profile for therapeutic use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If WPRE is used in retroviral vectors, then transgene expression is enhanced, but tumorigenic risk increases due to X-protein expression
Solution Approach 1:
The invention extracts and removes the harmful X-protein coding sequence from the WPRE element, retaining only the beneficial post-transcriptional regulatory functions. This is achieved by deleting the X-protein open reading frame while preserving the 3' UTR sequences that enhance mRNA stability and translation, thereby eliminating tumorigenic risk while maintaining transgene expression enhancement.
Solution Approach 2:
The invention introduces an intermediary element - a modified WPRE sequence (WPREΔX or WPREmut) that mediates between the conflicting requirements of high transgene expression and low tumorigenicity. This modified element serves as a bridge, providing the regulatory functions of WPRE without the harmful X-protein expression, thus resolving the contradiction through a mediating structure.
2Object-affected harmful factors
If WPRE is removed to eliminate tumorigenicity, then safety improves, but transgene expression decreases
Solution Approach 1:
Instead of removing the entire WPRE element, the invention selectively extracts only the harmful X-protein coding portion while retaining the essential regulatory sequences in the 3' UTR. This partial extraction approach maintains the beneficial post-transcriptional enhancement functions while eliminating the tumorigenic X-protein, thus avoiding the loss of transgene expression.
Solution Approach 2:
The invention applies local quality modification by creating a heterogenous WPRE structure where different regions have different functions: the 5' region is modified to eliminate X-protein coding capacity, while the 3' UTR region is preserved to maintain mRNA stability and translation enhancement. This localized modification strategy ensures safety without sacrificing expression efficiency.
3Object-affected harmful factors
If mutant WPRE is used to reduce tumorigenicity, then safety improves, but reversion to wild-type sequence is possible due to low reverse transcriptase fidelity
Solution Approach 1:
The invention inverts the traditional approach by not relying on point mutations to eliminate tumorigenicity, but rather by complete deletion or replacement of the X-protein coding sequence with non-functional sequences. This reversal of strategy - from subtle mutation to fundamental structural change - eliminates the possibility of reversion, as the reverse transcriptase cannot reconstruct the deleted X-protein ORF from the modified sequences.
Solution Approach 2:
The invention performs preliminary action by designing the modified WPRE element with irreversible changes to the X-protein coding sequence during vector construction. The deletion or replacement is built into the vector design from the outset, preventing any possibility of reversion during reverse transcription and integration, thus ensuring long-term genetic stability and safety.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a vector system involving replacement of a Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (WPRE) sequence with an unrelated short spacer sequence for efficient expression of nucleotides of interest in a retroviral vector system and methods of delivering and expressing nucleotides of interest to target cells.